Recent Progress in the Drug Development Targeting SARS-CoV-2 Main Protease as Treatment for COVID-19

The sudden outbreak of 2019 novel coronavirus (2019-nCoV, later named SARS-CoV-2) rapidly turned into an unprecedented pandemic of coronavirus disease 2019 (COVID-19). This global healthcare emergency marked the third occurrence of a deadly coronavirus (CoV) into the human society after entering the...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Wen, Yang, Kailin, Yang, Haitao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746807/
https://www.ncbi.nlm.nih.gov/pubmed/33344509
http://dx.doi.org/10.3389/fmolb.2020.616341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7746807/
https://www.ncbi.nlm.nih.gov/pubmed/33344509
http://dx.doi.org/10.3389/fmolb.2020.616341

Ejemplares similares